BiotechTube

Transdermal estradiol gel + Micronized Progesterone + Placebo for estradiol gel + Placebo for micronized progesterone

ApprovedRecruiting
0 watching 0 views this week🔥 Hot
80
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
✓
Phase 3
5
Approved
Indication / Disease

HIV Infection

Conditions

HIV Infection, Menopause

Trial Timeline

Jan 19, 2026 → Sep 20, 2027

NCT ID
NCT06856174

About Transdermal estradiol gel + Micronized Progesterone + Placebo for estradiol gel + Placebo for micronized progesterone

Transdermal estradiol gel + Micronized Progesterone + Placebo for estradiol gel + Placebo for micronized progesterone is a approved stage product being developed by Allergy Therapeutics for HIV Infection. The current trial status is recruiting. This product is registered under clinical trial identifier NCT06856174. Target conditions include HIV Infection, Menopause.

Hype Score Breakdown

Clinical
30
Activity
20
Company
5
Novelty
10
Community
12

Clinical Trials (1)

NCT IDPhaseStatus
NCT06856174ApprovedRecruiting

Competing Products

20 competing products in HIV Infection

See all competitors
ProductCompanyStageHype Score
BSG005Alkem LaboratoriesPhase 1/2
41
Zotatifin + PlaceboeFFECTOR TherapeuticsPhase 1
25
AAVLP-HPV + Placebo2A PharmaPhase 1
25
CT-P59CelltrionPhase 1
33
CT-P63 + PlaceboCelltrionPhase 1
33
CT-P59 + CT-P59 + Placebo + CT-P59 + PlaceboCelltrionPhase 2/3
65
CT-P59 + PlaceboCelltrionPhase 1
33
SOF + COPEChugai PharmaceuticalPre-clinical
23
Edoxaban Tablets + Colchicine TabletsDaiichi SankyoPhase 3
77
VN-0200 + PlaceboDaiichi SankyoPhase 1
33
VN-0200Daiichi SankyoPhase 2
52
Levofloxacin + Solifenacin succinate + Placebo (for Solifenacin succinate)Astellas PharmaApproved
85
MicafunginAstellas PharmaPhase 1
33
MicafunginAstellas PharmaPre-clinical
23
amphotericin B liposomal (Ambisome)Astellas PharmaApproved
85
Parenteral micafungin application + Other parenteral antifungal drugsAstellas PharmaPre-clinical
23
Fidaxomicin + Treatment for CDI other than fidaxomicin TypeAstellas PharmaPre-clinical
23
Isavuconazonium sulfate + Voriconazole + PosaconazoleAstellas PharmaPre-clinical
23
Ciclosporin and Mycophenolate-mofetil + Tacrolimus and Mycophenolate-mofetil + Tacrolimus and Mycophenolate-mofetil with change from Mycophenolate-mofetil to EverolimusAstellas PharmaApproved
85
DOR/ISLMerckPhase 2
52

Other Products from Allergy Therapeutics

Atripla (r) + Efavirenz + Truvada + Rifampin/isoniazid/pyrazinamide/ethambutol FDC + Rifampin/isoniazid FDC + IsoniazidApproved
80
Doravirine 100 Mg + Integrase strand transfer inhibitors + Tenofovir alafenamide/emtricitabine + tenofovir disproxil fumarate/emtricitabineApproved
80
Sofosbuvir/Velpatasvir (SOF/VEL)Approved
80
Efavirenz + Emtricitabine/Tenofovir disoproxil fumarateApproved
80
Atazanavir + Didanosine (enteric-coated) + Efavirenz + Emtricitabine + Emtricitabine/Tenofovir disoproxil fumarate + Lamivudine/ZidovudineApproved
80